Explore comprehensive CDMO services offered by VGXI, supporting end-to-end Anlaytical Testing, Drug Development and Manufacturing. VGXI enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: U.S.A.
Description: VGXI is a contract development and manufacturing organization (CDMO) that specializes in the production of DNA-based pharmaceuticals, such as DNA vaccines, cell and gene therapies. Founded in 1997 and based in Conroe, Texas, the company provides services from pre-clinical research through commercial supply, adhering to strict Current Good Manufacturing Practices (cGMP). Key services include process development, cell banking, and producing high-purity plasmid DNA using its proprietary AIRMIX® technology.
